How do I find a HER2-Positive Breast Cancer specialist vs a general oncologist

Her__positive_breast_cancerMay 23, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Finding a HER2-Positive Breast Cancer Specialist

Great question—this is an important decision that can significantly impact your care. Let me break down how to find the right specialist and what to look for.

Why a Specialist Matters for HER2-Positive Breast Cancer

HER2-positive breast cancer is a specific subtype that requires expertise in targeted therapies. According to the CancerPatientLab webinars on breast cancer, HER2 is one of the most important therapeutic biomarkers in oncology—meaning your treatment options are very different from other breast cancer types, and the field is rapidly evolving with new drugs being approved regularly.

As one expert noted, HER2-driven breast cancer can be treated with anti-HER2 strategies, and newer options like trastuzumab deruxtecan (Enhertu) and dual HER2-targeted combinations are changing outcomes. A specialist will know these nuances; a general oncologist may not.

How to Find a HER2-Positive Breast Cancer Specialist

1. Start with Cancer Research Centers

  • Look for National Cancer Institute (NCI)-designated cancer centers or comprehensive cancer centers in your region
  • These centers typically have breast cancer specialists with deep expertise in HER2-positive disease
  • Many community hospitals have relationships with major cancer research centers and can refer you or consult virtually

2. Ask Your Current Oncologist for a Referral

  • Request a referral to a breast cancer specialist, specifically mentioning your HER2-positive status
  • If your current doctor seems unfamiliar with newer HER2 treatments (like Enhertu or dual HER2 combinations), this is a signal you may benefit from a specialist opinion

3. Check Professional Organizations

  • NCCN (National Comprehensive Cancer Network) maintains guidelines and can help you find specialists
  • ASCO (American Society of Clinical Oncology) has a "Find an Oncologist" tool
  • American Cancer Society provides resources for finding breast cancer specialists

4. Look for These Credentials

  • Board certification in medical oncology with breast cancer focus
  • Active involvement in breast cancer research or clinical trials
  • Membership in breast cancer-focused organizations
  • Experience with HER2-positive cases and newer targeted therapies

Questions to Ask When Evaluating a Specialist

According to patient advocacy guidance from CancerPatientLab, here are critical questions:

About Their Expertise:

  • "How many HER2-positive breast cancer patients do you treat annually?"
  • "Are you familiar with newer HER2-targeted therapies like trastuzumab deruxtecan (Enhertu)?"
  • "Do you stay current with the latest NCCN guidelines for HER2-positive breast cancer?"

About Your Specific Care:

  • "What additional testing would you recommend for my case?" (This might include comprehensive genomic profiling, liquid biopsy, or proteomic testing)
  • "Are there clinical trials appropriate for my HER2-positive status?"
  • "Under what circumstances would you change treatment if current options aren't effective?"

About Treatment Philosophy:

  • "How do you approach treatment decisions—do you use precision medicine approaches?"
  • "Would you be open to discussing treatment options beyond standard of care if my tumor profile suggests they might help?"

Specialist vs. General Oncologist: Key Differences

| Aspect | General Oncologist | HER2 Specialist | |--------|-------------------|-----------------| | Breadth | Treats many cancer types | Deep expertise in breast cancer, especially HER2+ | | Latest drugs | May know standard options | Likely familiar with newest HER2-targeted therapies | | Clinical trials | Limited breast cancer trial access | Often connected to breast cancer trial networks | | Precision medicine | May be less familiar | More likely to order advanced testing | | Treatment nuance | Follows guidelines broadly | Understands HER2-specific treatment sequencing |

Important Considerations

You Don't Have to Choose Just One: Many patients benefit from having both a general oncologist for overall care coordination AND a specialist for HER2-specific treatment decisions. Some specialists are willing to co-manage care with your local oncologist.

Insurance and Access:

  • Check your insurance coverage before scheduling
  • Ask about financial assistance programs for advanced diagnostic testing
  • Some specialists offer virtual consultations if travel is difficult

Red Flags for a Specialist:

  • Unfamiliar with drugs like Enhertu, pertuzumab, or trastuzumab
  • Reluctant to discuss or order comprehensive genomic testing
  • Not aware of current NCCN guidelines for HER2-positive breast cancer
  • Dismissive of your questions about newer treatment options

Next Steps

  1. Request your pathology report to confirm HER2-positive status and get other details (ER/PR status, stage, grade)
  2. Ask your current doctor for a specialist referral or second opinion
  3. Contact your nearest NCI-designated cancer center and ask for a breast cancer specialist with HER2 expertise
  4. Prepare a list of questions before your first appointment with a specialist

According to CancerPatientLab guidance on patient advocacy, being an active advocate for yourself—asking about genomic testing, precision medicine options, and specialist expertise—is one of the most important things you can do for your care.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: